The history of Viagra, and its developer copyright, presents a challenging case study for investors. Initially a blockbuster drug, yielding billions in revenue , its exclusivity period created a deluge of knock-off medications, significantly diminishing its position . While some pharmaceutical companies may seek to capitalize on related treatments